Literature DB >> 7556872

Structure of the human luteinizing hormone-choriogonadotropin receptor gene: unusual promoter and 5' non-coding regions.

M Atger1, M Misrahi, S Sar, L Le Flem, P Dessen, E Milgrom.   

Abstract

The complete organization of the human luteinizing hormone-choriogonadotropin (LH/CG) receptor (LH/CGR) gene and the structure of 1591 bp of its 5' flanking region have been determined. This gene spans over 70 kbp and contains 11 exons. The first ten exons and part of the last exon encode the extracellular domain of the receptor while the transmembrane and intracellular domains are encoded by the remaining part of the last exon. The gene encodes a 701 amino acids long preprotein, contrary to a previous report of 699 amino acids. Primer extension experiments and polymerase chain reaction (PCR) mapping allowed definition of the transcription initiation site, which is located 1085 bp upstream from the initiation codon. The 5' non-coding region is thus unusually long. The promoter region which is different from the murine LH/CG receptor promoter, contains two putative TATA boxes at positions -34 and -47 and a CAAT box consensus sequence at position -89. A consensus sequence corresponding to a cAMP responsive element is found at position -697. Seven API consensus sequences are also found in the 5' flanking region of the gene. Southern blot experiments demonstrated an informative biallelic polymorphism within the human LH/CG receptor gene locus using BglII endonuclease. The cloning of the human LH/CGR gene and the determination of the organization and structure of its 5' flanking region allow the study of its hormonal, developmental and tissue-specific regulation. Primers and PCR conditions are described for the direct genomic sequencing of all the exons of the gene. This information should facilitate the study of pathological mutations of the receptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7556872     DOI: 10.1016/0303-7207(95)03557-n

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  14 in total

1.  LH (Trp8Arg/Ile15Thr), LHR (insLQ) and FSHR (Asn680Ser) polymorphisms genotypic prevalence in women with endometriosis and infertility.

Authors:  Carla Regina Schmitz; Carlos Augusto Bastos de Souza; Vanessa Krebs Genro; Ursula Matte; Emily de Conto; João Sabino Cunha-Filho
Journal:  J Assist Reprod Genet       Date:  2015-05-03       Impact factor: 3.412

Review 2.  Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function.

Authors:  Livio Casarini; Elisa Pignatti; Manuela Simoni
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

3.  A novel compound heterozygous mutation of the luteinizing hormone receptor -implications for fertility.

Authors:  Frederic Mitri; Yaakov Bentov; Lucy Ann Behan; Navid Esfandiari; Robert F Casper
Journal:  J Assist Reprod Genet       Date:  2014-05-22       Impact factor: 3.412

Review 4.  TSH receptor autoantibodies.

Authors:  Krzysztof Michalek; Syed A Morshed; Rauf Latif; Terry F Davies
Journal:  Autoimmun Rev       Date:  2009-03-27       Impact factor: 9.754

5.  Microvesicle-mediated release of soluble LH/hCG receptor (LHCGR) from transfected cells and placenta explants.

Authors:  Anne E Chambers; Paul F Stanley; Harpal Randeva; Subhasis Banerjee
Journal:  Reprod Biol Endocrinol       Date:  2011-05-15       Impact factor: 5.211

6.  A link between high serum levels of human chorionic gonadotrophin and chorionic expression of its mature functional receptor (LHCGR) in Down's syndrome pregnancies.

Authors:  Subhasis Banerjee; Alan Smallwood; Anne E Chambers; Aris Papageorghiou; Hugues Loosfelt; Kevin Spencer; Stuart Campbell; Kypros Nicolaides
Journal:  Reprod Biol Endocrinol       Date:  2005-06-21       Impact factor: 5.211

7.  Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation.

Authors:  Travis J O'Brien; Mariah M Kalmin; Arthur F Harralson; Adam M Clark; Ian Gindoff; Samuel J Simmens; David Frankfurter; Paul Gindoff
Journal:  Reprod Biol Endocrinol       Date:  2013-07-25       Impact factor: 5.211

8.  Quantitative ELISAs for serum soluble LHCGR and hCG-LHCGR complex: potential diagnostics in first trimester pregnancy screening for stillbirth, Down's syndrome, preterm delivery and preeclampsia.

Authors:  Anne E Chambers; Christopher Griffin; Samantha A Naif; Ian Mills; Walter E Mills; Argyro Syngelaki; Kypros H Nicolaides; Subhasis Banerjee
Journal:  Reprod Biol Endocrinol       Date:  2012-12-17       Impact factor: 5.211

9.  GnRH and LHR gene variants predict adverse outcome in premenopausal breast cancer patients.

Authors:  Djura Piersma; Axel P N Themmen; Maxime P Look; Jan G M Klijn; John A Foekens; André G Uitterlinden; Huibert A P Pols; Els M J J Berns
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

10.  A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E epsilon4 allele.

Authors:  Ryan J Haasl; M Reza Ahmadi; Sivan Vadakkadath Meethal; Carey E Gleason; Sterling C Johnson; Sanjay Asthana; Richard L Bowen; Craig S Atwood
Journal:  BMC Med Genet       Date:  2008-04-25       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.